County officials also reported significant increases in the rates of domestic abuse, suicide, and OxyContin abuse.
From 1952 they turned Purdue Pharma into a large privately owned business with products including OxyContin.
In August 2010, Purdue Pharma reformulated their long-acting oxycodone line, marketed as OxyContin, to use an abuse-resistant polymer designed to decrease abuse potential by defeating the release mechanism.